|
RFX5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.492400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.719800E-01 |
| Normal-vs-Stage2 |
2.425800E-02 |
| Normal-vs-Stage3 |
6.899900E-02 |
| Normal-vs-Stage4 |
5.536600E-01 |
| Stage1-vs-Stage2 |
9.592100E-02 |
| Stage1-vs-Stage3 |
2.609400E-01 |
| Stage1-vs-Stage4 |
9.232200E-01 |
| Stage2-vs-Stage3 |
4.403200E-01 |
| Stage2-vs-Stage4 |
2.580800E-01 |
| Stage3-vs-Stage4 |
5.068600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.661780E-01 |
| Normal-vs-AfricanAmerican |
5.519200E-01 |
| Normal-vs-Asian |
6.575800E-01 |
| Caucasian-vs-AfricanAmerican |
1.933800E-01 |
| Caucasian-vs-Asian |
4.494200E-01 |
| AfricanAmerican-vs-Asian |
4.041400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.149600E-02 |
| Normal-vs-Female |
2.307200E-01 |
| Male-vs-Female |
2.670600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.975200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.354560E-01 |
| Normal-vs-Age(61-80Yrs) |
9.751900E-02 |
| Normal-vs-Age(81-100Yrs) |
5.728200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.902000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.698000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.541400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.854800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.710000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.829400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.448400E-01 |
| Classical-VS-Follicular |
7.84450000000936E-05 |
| Classical-VS-Other |
9.112200E-02 |
| Classical-VS-Normal |
5.866400E-01 |
| Tall-VS-Follicular |
1.076380E-02 |
| Tall-VS-Other |
7.239600E-02 |
| Tall-VS-Normal |
8.267800E-01 |
| Follicular-VS-Other |
7.094400E-01 |
| Follicular-VS-Normal |
8.426100E-04 |
| Other-VS-Normal |
3.845600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.296400E-02 |
| Normal-vs-N1 |
4.899700E-02 |
| N0-vs-N1 |
8.414600E-01 |
|
|
